Recombinant factors of blood coagulation;Rekombinante faktoren der blutgerinnung

Pharmazie in Unserer Zeit

Volumn 35, Issue 1, 2006, Pages 40-45

  Bödeker, Berthold ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9;

BIOREACTOR; BLOOD CLOTTING; BLOOD COMPONENT THERAPY; CELL STRAIN BHK; CHO CELL; DRUG FORMULATION; HEMOPHILIA; HUMAN; NONHUMAN; PLASMA; REVIEW; SUSPENSION CELL CULTURE; VIRUS INACTIVATION;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HUMANS; RECOMBINANT PROTEINS;

EID: 31344443454     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200500154     Document Type: Review

References (6)

1. Mammen, F., Gellissen, G.: Gene technology - Advances in the treatment of hemostatic and thrombotic disorders. Semin. Thromb. Hemost. 27 (2001).
2. Boedeker, B.G.D.: Production processes of licensed recombinant factor VIII preparations. Semin. Thromb. Hemost. 27 (2001), 385-395.
3. Jurlander, B., Thim, L., Klausen, N.K., et al.: Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development. Semin. Thromb. Hemost. 27 (2001), 373-384.
4. Harrison, S., Adamson, S., Bonam, D., et al.: The manufacturing process for recombinant factor IX. Semin. Hematol. 35 (1998), 4-10.
5. Brackmann, H.-H., Schwaab, R., Oldenburg, J., Schramm, W.: Klinische Anwendung plasmatischer und rekombinanter Gerinnungsfaktoren, Uni-Med Bremen (2003), 104-112.
6. Ewenstein, B.M., Collins, P., Tarantino, M.D., et al.: Hemophilia Therapy Innovation: Development of an Advanced Category Recombinant Factor VIII by a Plasma/Albumin-Free Method. Semin. Hematol. 41 (2004), 1-18.